Nunavik’s school board is turning to the community to help improve the success of its students. The first stop was a community consultation in Kuujjuaq on Oct. 9.
Exscientia researchers combined ‘565 with the BTK inhibitor zanubrutinib and observed deeper, more durable efficacy responses in xenograft models of B-cell malignancies, with long-lasting tumour ...